Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA’s Planned Lab Closings Draw More Questions From Congress

This article was originally published in The Tan Sheet

Executive Summary

House Democrats are seeking to deny FDA funding to implement its plan to close seven field labs, saying the changes would "drastically undercut" the agency's food safety oversight capabilities

You may also be interested in...



FDA Reconsiders ORA Reorganization As Questions From Congress Continue

FDA's Aug. 1 decision to temporarily suspend plans to close seven of its 13 field laboratories as part of its Office of Regulatory Affairs reorganization follows repeated protests and inquiries from Capitol Hill, including a July 31 letter from two of the proposal's chief critics

FDA Reconsiders ORA Reorganization As Questions From Congress Continue

FDA's Aug. 1 decision to temporarily suspend plans to close seven of its 13 field laboratories as part of its Office of Regulatory Affairs reorganization follows repeated protests and inquiries from Capitol Hill, including a July 31 letter from two of the proposal's chief critics

FDA Reconsiders ORA Reorganization As Questions From Congress Continue

FDA's Aug. 1 decision to temporarily suspend plans to close seven of its 13 field laboratories as part of its Office of Regulatory Affairs reorganization follows repeated protests and inquiries from Capitol Hill, including a July 31 letter from two of the proposal's chief critics

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS100569

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel